OR WAIT null SECS
January 09, 2015
A guidance document published just before the Jan. 1, 2015 deadline adds a four-month grace period.
January 06, 2015
The exclusivity deal mirrors that of the recent deal between Express Scripts and AbbVie for Viekira Pak.
January 05, 2015
Isis Pharmaceuticals announced that it entered into an agreement with Janssen Biotech to discover and develop antisense drugs for autoimmune disorders of the GI tract.
December 29, 2014
Roche’s LightMix Ebola test can give results in around three hours.
When used in combination with chlorambucil to treat chronic lymphocytic leukemia, Gazyva was found to be more effective than Rituxan.
Entrectinib has received FDA’s orphan drug and rare pediatric disease designations for the treatment of neuroblastoma.
December 23, 2014
Approval of anti-PD-1 antibody Opdivo represents a major milestone for patients who no longer respond to existing treatments for melanoma.
December 22, 2014
Pharmacy benefit manager Express Scripts offers Viekira Pak at a discount and excludes the drug’s higher-priced competitors from its formulary.
December 19, 2014
The first stem-cell medication approved in the EU promotes regeneration and healing to the outer layer of the cornea.
December 18, 2014
Fujifilm Diosynth Biotechnologies announced the completion of the acquisition of Kalon Biotherapeutics, a company that specializes in advanced biologics development manufacturing.